A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes.
from Medical Xpress - latest medical and health news stories https://ift.tt/vdy0BuS
